QVIDTVM Management LLC
In its 13F for Q4 2024 (holdings as of December 31, 2024, filed February 13, 2025), QVIDTVM Management LLC reported 8 stock positions worth $124.2 million. Its top holding was Bio-Rad Laboratories-A (BIO) at 31.5% of the portfolio, followed by Solventum (SOLV, 29.9%) and Rentokil Initial PLC-SP ADR (RTO, 13.2%). Compared with Q3 2024, it added to 4 and reduced 3. The biggest buy was Solventum (SOLV, shares +13%) and the biggest sale Wabtec (WAB, shares −63%).
- Most Recent 13F
- Q2 2026
- Location
- THE WOODLANDS, TX
- CIK
- 0001912226
- Portfolio Value
- $124.2M (Q4 2024)
- SEC Filing
- 0001912226-25-000001 ↗ filed Feb 13, 2025
Holdings Value
Holdings 8 stocks · $124.2M
| BIO Bio-Rad Laboratories-A | 31.47% | 118,947 | $39.1M | Reduce -5.5% |
| SOLV Solventum Corp. | 29.92% | 562,276 | $37.1M | Add +13.1% |
| RTO Rentokil Initial PLC-SP ADR | 13.24% | 649,176 | $16.4M | Reduce -13.5% |
| BRC INC-A | 8.37% | 3,278,634 | $10.4M | Add +1.8% |
| XRAY Dentsply Sirona Inc. | 7.01% | 458,866 | $8.7M | No change |
| WAB Wabtec Corp. | 6.16% | 40,334 | $7.6M | Reduce -62.8% |
| ZGN Ermenegildo Zegna NV | 2.52% | 378,786 | $3.1M | Add +28.2% |
| OMIC Singular Genomics Systems Inc. | 1.31% | 83,671 | $1.6M | Add +0.1% |
Portfolio Sells Q3 2024 → Q4 2024
Portfolio Buys Q3 2024 → Q4 2024
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 14 | $76.6M | BIO, NBIS, AMRZ, ORCL, SOLV |
| Q1 2026 | 14 | $81.4M | BIO, SOLV, AMRZ, NBIS, ORCL |
| Q4 2025 | 13 | $88.4M | BIO, SOLV, AMRZ, XRAY, ZGN |
| Q3 2025 | 8 | $92.9M | SOLV, BIO, COTY, XRAY, BRC INC-A |
| Q2 2025 | 8 | $99.8M | SOLV, BIO, COTY, XRAY, RTO |
| Q1 2025 | 8 | $113.1M | SOLV, BIO, RTO, COTY, XRAY |
| Q4 2024 | 8 | $124.2M | BIO, SOLV, RTO, BRC INC-A, XRAY |
| Q3 2024 | 8 | $142.9M | BIO, SOLV, WAB, RTO, XRAY |
| Q2 2024 | 7 | $125.0M | BIO, RTO, SOLV, WAB, BRC INC-A |
| Q1 2024 | 10 | $124.2M | BIO, RTO, WAB, BRC INC-A, XRAY |